No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patients

C M Wilcox1, K B Waites, P D Smith

  • 1Departments of Medicine (Gastroenterology and Hepatology) and Pathology, University of Alabama at Birmingham, Birmingham, AL 39294-0007, USA.

Gut
|December 24, 1998
PubMed
Abstract

Insights

Small bowel bacterial overgrowth is uncommon in patients with Human Immunodeficiency Virus type 1 (HIV-1) infection. Bacterial quantity and species did not correlate with diarrhea, gastric acidity, or immune deficiency severity.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Limited conclusive studies exist on small bowel bacterial overgrowth (SBBO) in Human Immunodeficiency Virus type 1 (HIV-1) infected patients.
  • Investigating the relationship between proximal small intestine bacterial composition and clinical factors in HIV-1 is crucial.

Purpose of the Study:

  • To determine the relationship between the quantity and species of bacteria in the proximal small intestine of HIV-1 infected patients.
  • To assess the correlation with diarrhea, gastric acidity, immune deficiency severity, and clinical outcome.

Main Methods:

  • Duodenal fluids from 32 HIV-1 patients (21 with diarrhea) and 7 controls were analyzed for bacterial quantification and speciation.
  • Gastric pH was measured during endoscopy, and clinical follow-up was conducted.

Main Results:

  • Oropharyngeal Gram-positive cocci were prevalent (88%).
  • Gram-negative aerobic/facultative anaerobic bacteria (38%) and strict anaerobes (19%) were detected, but colony counts rarely exceeded 10(4) CFU/ml.
  • Bacterial numbers and species did not correlate with diarrhea, gastric pH, or CD4+ T-cell count.

Conclusions:

  • Small bowel bacterial overgrowth is not common in HIV-1 infected patients.
  • SBBO is not associated with diarrhea or hypochlorhydria in this population.

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
Drug Absorption: Factors Affecting GI Absorption01:19

Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...